In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience.

Angela Quirino,Claudia Cicino,Vincenzo Scaglione,Nadia Marascio,Francesca Serapide,Giuseppe Guido Maria Scarlata,Rosaria Lionello,Francesca Divenuto,Valentina La Gamba,Grazia Pavia,Alessandro Russo,Carlo Torti,Giovanni Matera,Enrico Maria Trecarichi

Mediterranean journal of hematology and infectious diseases（2023）

引用 0|浏览4

暂无评分

摘要

Introduction: Cefiderocol (CFDC) is a novel siderophore cephalosporin with broad-spectrum activity against carbapenem-resistant Gram-negative bacteria. Gram-negative bacterial isolates' resistance to cefiderocol (CFDC) is emerging in clinical practice.

查看译文

关键词

acinetobacter,cefiderocol,clinical isolates,carbapenem-resistant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要